Tissue Repair Ltd (ASX:TRP)

Market Cap	13.30M
Revenue (ttm)	2.39M
Net Income (ttm)	-4.44M
Shares Out	60.46M
EPS (ttm)	-0.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	46,056
Average Volume	98,762
Open	0.2200
Previous Close	0.2200
Day's Range	0.2200 - 0.2200
52-Week Range	0.1850 - 0.5000
Beta	0.48
RSI	27.74
Earnings Date	May 28, 2025

About Tissue Repair

Tissue Repair Ltd, a clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures. The company was incorporated in 2012 and is based in Chatswood, Australia.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2012
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: TRP

Financial Performance

In 2024, Tissue Repair's revenue was 1.79 million, an increase of 84.31% compared to the previous year's 971,655. Losses were -4.14 million, -0.87% less than in 2023.